# Federal Agricultural Mortgage Corp: financial statements, quarterly

AGM · NYSE · CIK 845877 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agm.md) · [Financials](/companies/agm/financials.md) · [Filings](/companies/agm/filings.md) · [Insiders](/companies/agm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/agm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [294](/filings/0000845877-23-000209.md) | [269 d](/filings/0000845877-24-000028.md) | [310](/filings/0000845877-24-000143.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.1](/filings/0000845877-24-000243.md) | [12.8 d](/filings/0000845877-26-000014.md) | [14.5](/filings/0000845877-25-000152.md) | [12.1](/filings/0000845877-25-000204.md) | [12.4](/filings/0000845877-25-000252.md) | [11.9 d](/filings/0000845877-26-000014.md) | [13.5](/filings/0000845877-26-000093.md) | [10.6](/filings/0000845877-26-000123.md) | [11.7](/filings/0000845877-25-000252.md) | [12.5 d](/filings/0000845877-26-000014.md) | [12.3](/filings/0000845877-26-000093.md) | [14.9](/filings/0000845877-26-000123.md) |
| Net income | $m | [58.1](/filings/0000845877-24-000243.md) | [47.6 d](/filings/0000845877-26-000014.md) | [53.7](/filings/0000845877-25-000252.md) | [47.1](/filings/0000845877-25-000252.md) | [49.8](/filings/0000845877-25-000252.md) | [56.5 d](/filings/0000845877-26-000014.md) | [49.7](/filings/0000845877-26-000123.md) | [54.8](/filings/0000845877-26-000123.md) | [55.0](/filings/0000845877-25-000252.md) | [47.9 d](/filings/0000845877-26-000014.md) | [59.1](/filings/0000845877-26-000123.md) | [67.0](/filings/0000845877-26-000123.md) |
| Diluted EPS | $ per share | [4.69](/filings/0000845877-24-000243.md) | not reported | [4.28](/filings/0000845877-25-000152.md) | [3.68](/filings/0000845877-25-000204.md) | [3.86](/filings/0000845877-25-000252.md) | not reported | [4.01](/filings/0000845877-26-000093.md) | [4.48](/filings/0000845877-26-000123.md) | [4.44](/filings/0000845877-25-000252.md) | not reported | [4.75](/filings/0000845877-26-000093.md) | [5.41](/filings/0000845877-26-000123.md) |
| Basic EPS | $ per share | [4.74](/filings/0000845877-24-000243.md) | not reported | [4.33](/filings/0000845877-25-000152.md) | [3.71](/filings/0000845877-25-000204.md) | [3.89](/filings/0000845877-25-000252.md) | not reported | [4.04](/filings/0000845877-26-000093.md) | [4.50](/filings/0000845877-26-000123.md) | [4.45](/filings/0000845877-25-000252.md) | not reported | [4.78](/filings/0000845877-26-000093.md) | [5.43](/filings/0000845877-26-000123.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0000845877-23-000209.md) | [0.9](/filings/0000845877-24-000243.md) | [0.7](/filings/0000845877-24-000143.md) | [0.9](/filings/0000845877-24-000201.md) | [0.8](/filings/0000845877-24-000243.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [28.3](/filings/0000845877-24-000243.md) | [29.5](/filings/0000845877-26-000014.md) | [29.8](/filings/0000845877-25-000152.md) | [30.2](/filings/0000845877-25-000204.md) | [30.6](/filings/0000845877-25-000252.md) | [31.3](/filings/0000845877-26-000014.md) | [31.8](/filings/0000845877-26-000093.md) | [33.0](/filings/0000845877-26-000123.md) | [33.4](/filings/0000845877-25-000252.md) | [35.4](/filings/0000845877-26-000123.md) | [36.7](/filings/0000845877-26-000093.md) | [39.3](/filings/0000845877-26-000123.md) |
| Total liabilities | $bn | [26.9](/filings/0000845877-23-000209.md) | [28.1](/filings/0000845877-25-000033.md) | [28.3](/filings/0000845877-24-000143.md) | [28.7](/filings/0000845877-24-000201.md) | [29.2](/filings/0000845877-24-000243.md) | [29.8](/filings/0000845877-26-000014.md) | [30.3](/filings/0000845877-25-000152.md) | [31.5](/filings/0000845877-25-000204.md) | [31.7](/filings/0000845877-25-000252.md) | [33.7](/filings/0000845877-26-000123.md) | [35.0](/filings/0000845877-26-000093.md) | [37.4](/filings/0000845877-26-000123.md) |
| Long-term debt | $bn | [17.6](/filings/0000845877-23-000209.md) | [18.5](/filings/0000845877-24-000028.md) | [17.9](/filings/0000845877-24-000143.md) | [17.8](/filings/0000845877-24-000201.md) | [17.2](/filings/0000845877-24-000243.md) | [17.1](/filings/0000845877-25-000033.md) | [17.9](/filings/0000845877-25-000152.md) | [18.6](/filings/0000845877-25-000204.md) | [19.1](/filings/0000845877-25-000252.md) | [19.5](/filings/0000845877-26-000014.md) | [20.8](/filings/0000845877-26-000093.md) | [21.9](/filings/0000845877-26-000123.md) |
| Current portion of debt | $bn | [8.0](/filings/0000845877-23-000209.md) | [8.1](/filings/0000845877-25-000033.md) | [8.9](/filings/0000845877-24-000143.md) | [9.0](/filings/0000845877-24-000201.md) | [9.9](/filings/0000845877-24-000243.md) | [10.4](/filings/0000845877-26-000014.md) | [10.1](/filings/0000845877-25-000152.md) | [10.3](/filings/0000845877-25-000204.md) | [10.1](/filings/0000845877-25-000252.md) | [11.3](/filings/0000845877-26-000123.md) | [11.5](/filings/0000845877-26-000093.md) | [12.9](/filings/0000845877-26-000123.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.4](/filings/0000845877-24-000243.md) | [1.4](/filings/0000845877-26-000014.md) | [1.5](/filings/0000845877-25-000252.md) | [1.5](/filings/0000845877-25-000252.md) | [1.5](/filings/0000845877-25-000252.md) | [1.5](/filings/0000845877-26-000123.md) | [1.5](/filings/0000845877-26-000123.md) | [1.5](/filings/0000845877-26-000123.md) | [1.7](/filings/0000845877-25-000252.md) | [1.7](/filings/0000845877-26-000123.md) | [1.7](/filings/0000845877-26-000123.md) | [1.9](/filings/0000845877-26-000123.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [363 d](/filings/0000845877-24-000243.md) | [(167) d](/filings/0000845877-26-000014.md) | [233](/filings/0000845877-25-000152.md) | [56.1 d](/filings/0000845877-25-000204.md) | [(44.4) d](/filings/0000845877-25-000252.md) | [368 d](/filings/0000845877-26-000014.md) | [(49.8)](/filings/0000845877-26-000093.md) | [(47.7) d](/filings/0000845877-26-000123.md) | [74.2 d](/filings/0000845877-25-000252.md) | [103 d](/filings/0000845877-26-000014.md) | [92.1](/filings/0000845877-26-000093.md) | [40.4 d](/filings/0000845877-26-000123.md) |
| Capital expenditure | $m | [0.0 d](/filings/0000845877-24-000243.md) | [0.0 d](/filings/0000845877-26-000014.md) | [1.6](/filings/0000845877-25-000152.md) | [3.6 d](/filings/0000845877-25-000204.md) | [0.1 d](/filings/0000845877-25-000252.md) | [0.0 d](/filings/0000845877-26-000014.md) | [0.0](/filings/0000845877-25-000152.md) | [0.0 d](/filings/0000845877-25-000204.md) | [0.0 d](/filings/0000845877-25-000252.md) | [0.0 d](/filings/0000845877-26-000014.md) | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000845877-26-000093.md) | [0.0 d](/filings/0000845877-26-000123.md) | not reported | not reported | [7.1](/filings/0000845877-26-000093.md) | [0.0 d](/filings/0000845877-26-000123.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.9](/filings/0000845877-23-000209.md) | [10.9](/filings/0000845877-24-000143.md) | [10.9](/filings/0000845877-24-000201.md) | [10.9](/filings/0000845877-24-000243.md) | [11.0](/filings/0000845877-25-000152.md) | [11.0](/filings/0000845877-25-000204.md) | [11.0](/filings/0000845877-25-000252.md) | [11.0](/filings/0000845877-26-000093.md) | [11.0](/filings/0000845877-26-000123.md) | [11.0](/filings/0000845877-25-000252.md) | [10.9](/filings/0000845877-26-000093.md) | [10.9](/filings/0000845877-26-000123.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.